E-LIB Suche - Ergebnisse für: Chaikin, Philip

1

Will the Pharmacologically Meaningful Half‐Life Please Stan..:

Chaikin, Philip ; Pai, Sudhakar M.
The Journal of Clinical Pharmacology. 62 (2022) 7 - p. 829-832 , 2022

2

Core Entrustable Professional Activities in Clinical Pharma..:

Donnenberg, Vera S. ; Chaikin, Philip ; Mandic, Maja...
The Journal of Clinical Pharmacology. 59 (2019) 7 - p. 915-922 , 2019

Link: https://doi.org/10.1002/..

3

Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, i..:

Pai, Sudhakar M. ; Chaikin, Philip ; Berg, Jolene Kay
The Journal of Clinical Pharmacology. 59 (2019) 10 - p. 1379-1383 , 2019

Link: https://doi.org/10.1002/..

4

Hemangiosarcoma in a Dog: Unusual Presentation and Increase..:

Chaikin, Philip ; Welihozkiy, Anja
Case Reports in Veterinary Medicine. 2018 (2018) - p. 1-6 , 2018

Link: https://doi.org/10.1155/..

5

Reply to Letter: The Use of IC50 for Potency and MTD as Obj..:

Chaikin, Philip
The Journal of Clinical Pharmacology. 57 (2017) 10 - p. 1359-1361 , 2017

Link: https://doi.org/10.1002/..

6

The Bial 10-2474 Phase 1 Study-A Drug Development Perspecti..:

Chaikin, Philip
The Journal of Clinical Pharmacology. 57 (2017) 6 - p. 690-703 , 2017

Link: https://doi.org/10.1002/..

7

Istradefylline for Parkinson's disease patients experiencin..:

Pourcher, Emmanuelle ; Fernandez, Hubert H. ; Stacy, Mark...
Parkinsonism & Related Disorders. 18 (2012) 2 - p. 178-184 , 2012

Link: https://doi.org/10.1016/..

8

Population Pharmacokinetic‐Pharmacodynamic Analysis of Istr..:

Knebel, William ; Rao, Niranjan ; Uchimura, T....
The Journal of Clinical Pharmacology. 52 (2012) 10 - p. 1468-1481 , 2012

Link: https://doi.org/10.1177/..

9

Population Pharmacokinetic Analysis of Istradefylline in He..:

Knebel, William ; Rao, Niranjan ; Uchimura, Tatsuo...
The Journal of Clinical Pharmacology. 51 (2011) 1 - p. 40-52 , 2011

Link: https://doi.org/10.1177/..

10

Adenosine A2A receptor antagonist istradefylline (KW‐6002) ..:

LeWitt, Peter A. ; Guttman, M. ; Tetrud, James W....
Annals of Neurology. 63 (2008) 3 - p. 295-302 , 2008

Link: https://doi.org/10.1002/..

11

The use of putative placebo in active control trials: two a..:

Durrleman, Sylvain ; Chaikin, Philip
Statistics in Medicine. 22 (2003) 6 - p. 941-952 , 2003

Link: https://doi.org/10.1002/..

12

Pharmacokinetics of doxorubicin administered i.v. as Myocet..:

Swenson, Christine E. ; Bolcsak, Lois E. ; Batist, Gerald...
Anti-Cancer Drugs. 14 (2003) 3 - p. 239-246 , 2003

Link: https://doi.org/10.1097/..

13

In Vitro and In Vivo Techniques Used in Drug Development fo..:

Rhodes, Gerald R. ; Rohatagi, Shashank ; Gillen, Michael S....
The Journal of Clinical Pharmacology. 41 (2001) 1 - p. 7-18 , 2001

Link: https://doi.org/10.1177/..

14

Effects of supratherapeutic doses of ebastine and terfenadi..:

Gillen, Michael S. ; Miller, Barry ; Chaikin, Philip.
British Journal of Clinical Pharmacology. 52 (2001) 2 - p. 201-204 , 2001

Link: https://doi.org/10.1046/..

15

Pharmacokinetic/Pharmacodynamic Modeling in Drug Research a..:

Derendorf, Hartmut ; Lesko, Lawrence J. ; Chaikin, Philip...
The Journal of Clinical Pharmacology. 40 (2000) 12 - p. 1399-1418 , 2000

Link: https://doi.org/10.1177/..